Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07101263 · ClinicalTrials.gov registry record · NA
Whey Protein Comparisons for Blood Lipid Effects
A NA study of Cholesterol, sponsored by Medinutra.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT07101263: Recruiting NA study of Cholesterol, sponsored by Medinutra.
NCT07101263 is a NA study of Cholesterol that is actively recruiting participants, run by Medinutra. The registered enrollment target is 72 participants, below the 763-participant average among 4 other Cholesterol trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07101263, a NA study of Cholesterol, is actively recruiting participants, sponsored by Medinutra.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if hydrolyzed whey protein can help serum cholesterol stay in normal range in adults. As a side inquiry, a few blood measures will be taken that are relevant to low level inflammation. The main questions the study aims to answer are: * Will hydrolyzed whey lower serum cholesterol readings in adults with starting values in the upper end of normal to the lower end of elevated? * Will the hydrolyzed whey affect a general measure of inflammation and two measures of indirect relevance to inflammation? Researchers will compare hydrolyzed whey to a conventional whey (a control protein not expected to affect serum cholesterol readings) to see if the hydrolyzed whey lowers serum cholesterol. Participants will: * Drink one protein beverage every day for 6 weeks; * Go to a LabCorp facility for a blood draw before and after the 6 weeks.
Primary Outcome
Serum total and LDL cholesterol (mg/dL) will be assessed
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Standard whey
- DIETARY_SUPPLEMENT Hydrolyzed whey
Study Locations (1)
Ohio
- Medinutra LLC - Dublin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2025-08-05 |
| Est. Completion | 2026-01-15 |
| Phase | NA |
What NCT07101263 shows while recruiting
NCT07101263 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 763-participant average among 4 other Cholesterol trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Cholesterol appearing as the primary indexed condition, and to 2 interventions - of which Standard whey is the first listed.
NCT07101263 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07101263 about?
NCT07101263 is a clinical study titled "Whey Protein Comparisons for Blood Lipid Effects". The goal of this clinical trial is to learn if hydrolyzed whey protein can help serum cholesterol stay in normal range in adults. As a side inquiry, a few blood measures will be taken that are relevant to low level inflammation. The main questions the study aims to answer are: * Will hydrolyzed whe...
What is the current status of trial NCT07101263?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2025-08-05. Estimated completion is 2026-01-15.
What conditions does trial NCT07101263 study?
This clinical trial studies the following conditions: Cholesterol.
What interventions are being tested in trial NCT07101263?
The interventions under investigation include: Standard whey (DIETARY_SUPPLEMENT), Hydrolyzed whey (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07101263?
This trial is sponsored by Medinutra, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07101263 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cholesterol
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Mental and Physical Health of Women Veterans
ACTIVE NOT RECRUITING · NA
-
Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1)
RECRUITING · Early Phase 1
-
Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)
RECRUITING · Early Phase 1
-
Interprofessional Pharmacogenomics (IPGx) Registry and Repository
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI